Apteki Pharma sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-06
Share capital
90,000.00 PLN
Registered address
ul. Aleje Prezydenta Lecha Kaczyńskiego 33, 85-806 Bydgoszcz, Poland
Electronic delivery address
AE:PL-60843-93319-EJETJ-27

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 77 days late).

  • 202519/06/2026
  • 202411/06/2025
  • 202330/04/2024
  • 202230/06/2023
  • 202130/09/2022
  • 202022/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 23%
Division · Retail trade1,762 / 9,987
Top 18%
City · Bydgoszcz268 / 3,083
Top 8.7%
Voivodeship · Kujawsko-Pomorskie1,242 / 11,436
Top 11%
Country · Poland29,384 / 297,069
Top 9.9%

Results vs industry

Revenue
This companyUSD 5.86mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD -390.53kMedianUSD 21.16kAverageUSD 85.84k
Operating costs
This companyUSD 6.10mMedianUSD 1.88mAverageUSD 5.06m
Assets
This companyUSD 1.70mMedianUSD 545.50kAverageUSD 1.76m

Public procurement

The company is the contractor in one public sector contract, worth USD 1.22k.

SubjectAmount
Provision by the training institution of training for students of the University’s Faculty of Pharmacy, pharmacy programme, as part of a six-month professional placement in a pharmacy.
$1,216

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2024. In 2026 it is performing 6 contracts with a total value of USD 1.20k. All its contracts were worth USD 2.81k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeskujawsko-pomorskie2USD 1.20k
Other services provided in pharmacieskujawsko-pomorskie4USD 0.00

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2005.

MarkNumberClassesStatusProtected until
POLSKIE APTEKI W EUROPIE LEKI ZA GROSZE Z.2931135Expired –
MarkProtected until
POLSKIE APTEKI W EUROPIE LEKI ZA GROSZE –

Authorized Representatives

Hubert Dotka age 39 – Management Board Member
Justyna Przybylska-Skrobisz age 37 – Management Board Member
Marcin Zygmunt Zieliński age 51 – Management Board Member
Paweł Miłosz Sobecki age 35 – Management Board Member
Sebastian Wróbel age 48 – Management Board Member

Manner of representation

In the case of a one-person management board, by the President of the Management Board. In the case of a multi-member management board, by two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
180$24,311.18100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-11-23.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $62,170.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,230
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,898
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,825

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragal sp. z o.o.
Modrzewscy sp. j.
Ms-Pharm sp. z o.o. + limited partnership
Farmjug Ag sp. z o.o.
Magmax S.A.
Adpharma sp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusik sp. j.
Novopharm - Miller sp. j.
Pikada sp. z o.o.
Vita sp. z o.o.

Change history

DateEvent
2019-01-07Address change
2017-06-21Share capital increase
2001-12-06Entered in the register

FAQ

Last updated: 2026-10-07